RASSF1B inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of RASSF1B, one of the alternatively spliced isoforms of the Ras Association Domain Family 1 (RASSF1) gene. RASSF1 plays an important role in cellular regulation by participating in processes such as apoptosis, cell cycle control, and cytoskeletal organization. Each isoform of the RASSF1 gene, including RASSF1B, performs distinct functions in these regulatory pathways. RASSF1B, in particular, is involved in modulating cellular responses to external signals that influence cell growth, survival, and differentiation. The protein interacts with Ras GTPases and other key signaling molecules to exert its regulatory effects. Inhibitors of RASSF1B work by binding to specific functional domains of the protein, disrupting its ability to interact with other proteins and signaling complexes, thereby impeding its role in regulating cellular processes.
The inhibition of RASSF1B has a direct impact on the signaling pathways in which it is involved, particularly those related to cell cycle regulation and apoptosis. By blocking the ability of RASSF1B to form critical protein-protein interactions, these inhibitors interfere with the control mechanisms that manage cellular growth, division, and programmed cell death. Researchers utilize RASSF1B inhibitors to explore the unique role of this isoform in comparison to other RASSF1 isoforms, such as RASSF1A, to understand the diversity of functions performed by each variant. This investigation also helps clarify how alternative splicing of the RASSF1 gene results in proteins that contribute to different cellular outcomes. The study of RASSF1B inhibitors also provides insights into the broader Ras signaling pathways, helping scientists understand how specific isoforms contribute to cellular homeostasis and the maintenance of a delicate balance between growth and apoptosis. Through these inhibitors, researchers gain a deeper understanding of the molecular mechanisms underlying cellular regulation and the impact of protein interactions on essential cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound could downregulate RASSF1B expression by causing DNA demethylation at the gene's promoter, thereby decreasing transcription initiation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine may lower RASSF1B levels by specifically targeting DNA methyltransferases for inhibition, leading to promoter demethylation and transcriptional repression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid could decrease RASSF1B expression by altering histone acetylation patterns, resulting in a condensed chromatin state less conducive to gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
This compound might reduce RASSF1B gene transcription by inhibiting histone deacetylase activity, leading to chromatin remodeling that silences gene expression. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
Romidepsin has the potential to inhibit RASSF1B expression by changing histone acetylation levels, which could suppress gene transcription. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
MS-275 may repress RASSF1B transcription by inhibiting histone deacetylase enzymes, resulting in compact chromatin that is transcriptionally inactive. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
This compound could inhibit RASSF1B expression by acting as a histone deacetylase inhibitor, which would alter the chromatin landscape around the gene locus. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate could indirectly decrease RASSF1B expression by disrupting folate metabolism, which is crucial for the generation of methyl groups used in DNA methylation. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram may indirectly inhibit RASSF1B expression by inhibiting aldehyde dehydrogenase, which might influence acetylation and the subsequent gene expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A could bind DNA in the promoter region of RASSF1B, inhibiting the binding of transcriptional machinery and thus downregulating the gene's expression. | ||||||